RIGL
Rigel Pharmaceuticals Inc. (New)
stockNASDAQ
Market OpenOct 22, 2026 12:23:13 PM EDT
49.05USD+0.348%(+0.17)31,584
RIGL Financials
In Q2 FY 2026 (ended ), Rigel Pharmaceuticals Inc. (New) (RIGL) reported revenue of $78.7M, net income of $17.29M, operating cash flow of $30.65M, and assets of $521.07M.
Loading financial statements…